已收盤 01-14 16:00:00 美东时间
0.000
0.00%
The Therapeutic Goods Administration (TGA) in Australia has updated its framework for psychedelic-assisted therapy (PAT), expanding therapist eligibility, allowing treatment in diverse settings, and enhancing scalability. Optimi Health Corp., a Canadian psychedelic pharmaceutical company, supplies MDMA for PTSD and psilocybin for treatment-resistant depression under the updated Authorized Prescriber (AP) scheme. Key changes include multidisciplin...
05-29 12:30
Mind Medicine Inc. (($DFTX)) has held its Q1 earnings call. Read on for the mai...
05-09 08:57
Stifel starts Definium coverage, citing strong DT120 potential in anxiety and key 2026 trial catalysts shaping outlook.
04-18 02:06
syence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced the expansion
04-08 21:18
https://www.marijuanamoment.net/bipartisan-senators-file-bill-to-support-psychedelics-research-and-treatment-for-veterans/
03-28 01:28
LSD therapy biotech Definium sued for alleged trade secret theft By Blake Brittain Feb 2 (Reuters) - A clinical-trial provider sued psychedelic therapy developer Definium Therapeutics DFTX.O on Monday in Delaware federal court, claiming it stole trade secrets related to LSD trials to share with a up
02-03 06:05
Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.) (the "Company" or "Definium") is updating its previous announcement that the Company's Common Shares would begin trading on Nasdaq under the ticker
01-13 20:20
Mind Medicine ( ($MNMD) ) just unveiled an announcement. On January 9, 2026, th...
01-12 21:56
Analysts are intrested in these 5 stocks: ( ($AME) ), ( ($MNMD) ), ( ($ATAI) ),...
2025-12-27 17:02
今日重点评级关注:Truist Securities:维持拜玛林制药"买入"评级,目标价从80美元升至100美元;HC Wainwright & Co.:维持Savara"买入"评级,目标价从8美元升至10美元
2025-12-24 11:17